mash and glp 1 Novo's Wegovy becomes first GLP-1 drug approved for What you need to know

Oxidative phosphorylation efficiency and ATP production change[8]

Many endocrinologists already prefer transdermal delivery for these reasons alone

However, the introduction of generic versions of GLP-1 receptor agonists may take time, as they must first go through patent expirations and regulatory processes

Patient safety is paramount at the FDA and we continuously review available sources of data and new information on potential risks of drugs, including GLP-1 receptor agonists, and update labeling as needed, an FDA spokesperson said in a statement

Cochrane Database of Systematic Reviews, 3, CD004454

So yes, the relative risk looked higher for GLP-1 users roughly about twice compared to some other medications